Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Other Operating Expenses (2025 - 2026)

Updated

Global Innovative Platforms' Other Operating Expenses was $288,931 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 42.4% from $202,856 a year earlier and up 12.8% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Other Operating Expenses (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Global Innovative Platforms' Other Operating Expenses was $565,726 through Jun 30, 2026, up 61.3% year-over-year.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 288,931.00
Mar 31, 2026 256,062.00
Sep 30, 2025 20,733.00
Jun 30, 2025 202,856.00
Mar 31, 2025 147,810.00
API Access

Global Innovative Platforms Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GIPL&period=max&api_key=YOUR_API_KEY